Jeffrey A. Conant Pmp, Mmgt (Jeff)

Senior Director Of Quality Operations at Nimbus Therapeutics

Jeffrey (Jeff) A. Conant is a highly experienced professional who has held various roles in the pharmaceutical industry. Jeffrey (Jeff) is currently serving as the Senior Director of Quality Operations at Nimbus Therapeutics, where they are responsible for managing the strategic and operational performance of the Quality function. Jeffrey (Jeff)'sprevious role was as the Director of Quality Systems at Rubius Therapeutics, where they oversaw the development of the Quality Management System (QMS) to support clinical and commercial operations.

Prior to these positions, Jeff worked at Takeda, where they served as the Director of QMS Systems & Logistics, and at Shire as the Director of QMS Technologies & Analytics. At both companies, they played a key role in developing and improving QMS technologies and processes to ensure compliance with regulatory requirements.

Jeff's earlier experience includes roles at Vertex Pharmaceuticals, Genzyme, Parexel, Massachusetts General Hospital, Massachusetts Institute of Technology, and Metpath. Throughout their career, they have demonstrated expertise in project management, program management, data management, and quality assurance.

Overall, Jeff A. Conant brings a wealth of experience and expertise to the pharmaceutical industry, with a strong focus on quality operations and compliance.

Jeffrey (Jeff) A. Conant, PMP, MMgt has a diverse education history. Jeffrey (Jeff) attended UMass Boston from 1987 to 1991 where they obtained a Bachelor of Science (BS) degree in Biology. Following that, they pursued further education at Cambridge College from 1992 to 1994 and earned a Master of Management (MMgt) degree in Finance.

In addition to their academic achievements, Jeff has also obtained two important certifications. In 2004, they became a certified Project Management Professional (PMP) through the Project Management Institute. Earlier in their career, Jeff served in the U.S. Marine Corps as a Nuclear Biological Chemical Defense Specialist for three years, ultimately receiving an honorable discharge.

Links

Previous companies

Parexel logo
Vertex Pharmaceuticals logo
Sanofi logo
Massachusetts General Hospital logo
Rubius Therapeutics logo
MIT logo